Ledger.Open graph →
SEC Form D · filed September 10, 2021

Aadi Bioscience, Inc

Offering
$155.0M
Sold
$155.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
Pacific Palisades, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (21)

Emma Reeve · Pacific Palisades, CADirectorRay Simpson · Philadelphia, PADirectorKarin Heneberger · Pacific Palisades, CADirectorAnupam Dalal · Pacific Palisades, CADirectorEric D. Mallon · Louisville, CODirectorCaley Castelein · Pacific Palisades, CADirectorGonzalo A. De La Melena · Phoenix, AZDirectorAdam C. Heflin · Phoenix, AZDirectorDonatien-Xavier Martin · Grand Duchy of Luxembourg, LuxembourgExecRay Croghan · Phoenix, AZDirectorJohn Hamer · Durham, NCDirectorNoel Carr · Philadelphia, PAExec · DirectorAnne Dean · CHICAGO, ILDirectorRichard Maroun · Pacific Palisades, CADirectorLance Thibault · Pacific Palisades, CAExecPatricia Costello · San Mateo, CADirectorNeil Desai · Pacific Palisades, CAExec · DirectorMitchell E. Goodman · IRVINE, CAExecJenna Poole · Maitland, FLDirectorGreg Bond · Maitland, FLExec · DirectorSteven Denbaars · Manchester, United KingdomDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗